Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
8
0
0
0
HTG Molecular Diagnostics, Inc.
Share · US40434H1041 · HTGM (XNAS)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of HTG Molecular Diagnostics, Inc.
Analyst Grade Summary
No Price
Share Float & Liquidity
Free Float 95,34 %
Shares Float 2,11 M
Shares Outstanding 2,21 M
Company Profile for HTG Molecular Diagnostics, Inc. Share
HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq DLBCL cell of origin assay; HTG EdgeSeq Oncology Biomarker Panel; HTG EdgeSeq ALKPlus assay EU; HTG EdgeSeq Pan B-Cell Lymphoma Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. HTG Molecular Diagnostics, Inc. has a governing agreement with QIAGEN Manchester Limited. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.
Company Data
Name HTG Molecular Diagnostics, Inc.
Company HTG Molecular Diagnostics, Inc.
Symbol HTGM
Website
https://www.htgmolecular.com
Primary Exchange 
NASDAQ
NASDAQ
ISIN US40434H1041
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO John L. Lubniewski
Country United States of America
Currency USD
Employees 0,1 T
Address 3430 East Global Loop, 85706 Tucson
IPO Date 2015-05-06
Stock Splits
| Date | Split |
|---|---|
| 21.12.2022 | 1:12 |
| 23.11.2020 | 1:15 |
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | HTGM |
More Shares
Investors who hold HTG Molecular Diagnostics, Inc. also have the following shares in their portfolio:
